Journal article
MBCL-09. SALVAGE THERAPY FOR CHILDHOOD MEDULLOBLASTOMA: A SINGLE CENTER EXPERIENCE
Abstract
Abstract
INTRODUCTION
Children diagnosed with medulloblastoma (MB) that are refractory to upfront therapy or experience recurrence have very poor prognoses. Reports of phase I and II studies for these children exist, but these therapies bear significant treatment related morbidity and mortality.METHODS
Authors
Kameda-Smith M; Wang A; Abdulhadi N; Adile A; Ajani O; Yarascavitch B; Farrokhyar F; Tina P; Samaan C; Alyman C
Journal
Neuro-oncology, Vol. 20, No. Suppl 2, pp. i119–i119
Publication Date
June 2018
ISSN
1522-8517